Price alert —
Sign in to get a one-time email the moment XNCR crosses your price. Free accounts included.
Sign in / create a free accountXencor, Inc. is a healthcare company listed in the US.
XNCR last traded at $17.47, up 16.9% on the day; that's in the upper part of its 52-week range ($10.38–$17.67). Right now it's stretched well above its recent average — moves this fast often cool off or give some back.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum is running hot (RSI 71, overbought territory), the trend is strong (ADX 37), and trading is unusually heavy at 1.6× normal volume. On the business side, revenue is shrinking 86% year over year and the business keeps about -61 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 4.94 (antifragile)
- ✓ Current ratio 6.25 (antifragile)
- ✓ Debt/equity 0.38 (antifragile)
- ⚠ Negative retained earnings
- ⚠ Stock comp 34% of revenue (heavy dilution)
XNCR is a $1.3 billion company, the stock is trading near the top of its 52-week range.